Clinical trial
Adjunctive Glycine for Obsessive Compulsive Disorder
NCT00405535 · Nathan Kline Institute for Psychiatric Research, Other · Completed
Key facts
| NCT number | NCT00405535 |
|---|---|
| Title | Adjunctive Glycine for Obsessive Compulsive Disorder |
| Official title | Adjunctive Glycine for Obsessive Compulsive Disorder |
| Lead sponsor | Nathan Kline Institute for Psychiatric Research, Other |
| Collaborators | Obsessive Compulsive Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obsessive Compulsive Disorder |
| Intervention type | Drug, Other |
| Interventions | glycine, placebo |
| Enrollment | 24 |
| Start date | Jun 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Nov 30, 2006 |
| Last update posted | Dec 16, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: